Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-31 Sale |
2025-02-04 11:53 am |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
4,551 | $11.14 | $50,698 | 178,541 (Direct) |
View |
| 2025-01-31 Sale |
2025-02-04 11:51 am |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
7,379 | $11.14 | $82,202 | 60,181 (Direct) |
View |
| 2024-09-09 Sale |
2024-09-12 1:54 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
859 | $13.08 | $11,236 | 148,425 (Direct) |
View |
| 2024-09-09 Sale |
2024-09-12 1:51 pm |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
1,521 | $13.08 | $19,895 | 31,893 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 1:15 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
5,153 | $13.08 | $67,401 | 164,284 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-20 4:38 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
12,000 | $14.05 | $168,600 | 139,437 (Direct) |
View |
| 2024-02-01 Sale(A) |
2024-02-05 9:16 pm |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
4,993 | $15.78 | $78,790 | 23,414 (Direct) |
View |
| 2024-02-01 Sale(A) |
2024-02-05 9:15 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
3,789 | $15.78 | $59,790 | 151,437 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:12 pm |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
4,993 | $15.74 | $78,590 | 55,748 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:07 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
3,789 | $15.74 | $59,639 | 169,438 (Direct) |
View |
| 2023-08-31 Sale |
2023-09-05 4:28 pm |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
3,800 | $18.01 | $68,438 | 18,407 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-31 Exercise |
2025-02-04 11:53 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
8,000 | $0 | 178,541 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 11:53 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
20,000 | $0 | 178,541 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-04 11:51 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
14,667 | $0 | 60,181 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 11:51 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
10,000 | $0 | 60,181 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 11:49 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
96,377 | $0 | 96,377 (Direct) |
View |
| 2024-10-08 Option Award |
2024-10-09 4:22 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Degnan Chris Chief Financial Officer |
87,592 | $0 | 87,592 (Direct) |
View |
| 2024-09-09 Exercise |
2024-09-12 1:54 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,666 | $0 | 148,425 (Direct) |
View |
| 2024-09-09 Exercise |
2024-09-12 1:51 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
3,333 | $0 | 31,893 (Direct) |
View |
| 2024-09-09 Exercise |
2024-09-12 1:50 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer |
2,500 | $0 | 42,753 (Direct) |
View |
| 2024-08-06 Option Award |
2024-08-08 09:11 am |
N/A 2034-08-06 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-08-06 Option Award |
2024-08-08 09:11 am |
N/A 2034-08-06 |
UroGen Pharma Ltd. | URGN | Cohen Fred E Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-08-06 Option Award |
2024-08-08 09:10 am |
N/A 2034-08-06 |
UroGen Pharma Ltd. | URGN | Wildman Daniel George Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-08-06 Option Award |
2024-08-08 09:09 am |
N/A 2034-08-06 |
UroGen Pharma Ltd. | URGN | Holden Stuart Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-08-06 Option Award |
2024-08-08 09:08 am |
N/A 2034-08-06 |
UroGen Pharma Ltd. | URGN | Robinson James A. Jr. Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-08-06 Option Award |
2024-08-08 09:07 am |
N/A 2034-08-06 |
UroGen Pharma Ltd. | URGN | WEN LEANA Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-08-06 Option Award |
2024-08-08 09:06 am |
N/A 2034-08-06 |
UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-06-10 Exercise |
2024-06-11 1:15 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
10,000 | $0 | 164,284 (Direct) |
View |
| 2024-01-31 Exercise(A) |
2024-02-12 5:47 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer |
3,333 | $0 | 35,253 (Direct) |
View |
| 2022-03-25 Option Award(A) |
2024-02-12 5:43 pm |
N/A 2032-03-25 |
UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 7:12 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
10,000 | $0 | 55,748 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 7:12 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
16,500 | $0 | 55,748 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 7:07 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
6,666 | $0 | 169,438 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 7:07 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
10,000 | $0 | 169,438 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 7:05 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer |
3,333 | $0 | 45,252 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 7:05 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer |
12,000 | $0 | 45,252 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 7:04 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
87,615 | $0 | 87,615 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 3:43 pm |
N/A 2033-09-07 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 3:43 pm |
N/A 2033-09-07 |
UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 3:42 pm |
N/A 2033-09-07 |
UroGen Pharma Ltd. | URGN | Cohen Fred E Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 3:42 pm |
N/A 2033-09-07 |
UroGen Pharma Ltd. | URGN | Wildman Daniel George Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 3:42 pm |
N/A 2033-09-07 |
UroGen Pharma Ltd. | URGN | Holden Stuart Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 3:41 pm |
N/A 2033-09-07 |
UroGen Pharma Ltd. | URGN | Robinson James A. Jr. Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 3:41 pm |
N/A 2033-09-07 |
UroGen Pharma Ltd. | URGN | WEN LEANA Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 3:41 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 3:41 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer |
7,500 | $0 | 7,500 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 3:40 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
5,000 | $0 | 5,000 (Direct) |
View |
| 2023-08-31 Exercise |
2023-09-05 4:28 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
8,334 | $0 | 18,407 (Direct) |
View |
| 2023-07-26 Option Award |
2023-07-28 6:06 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Cohen Fred E Director |
69,339 | $9.54 | 69,339 (Indirect) |
View |
| 2023-07-25 Option Award(A) |
2023-07-28 6:05 pm |
N/A 2033-07-25 |
UroGen Pharma Ltd. | URGN | Robinson James A. Jr. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-07-25 Option Award |
2023-07-27 4:30 pm |
N/A 2033-07-25 |
UroGen Pharma Ltd. | URGN | Robinson James A. Jr. Director |
20,000 | $0 | 20,000 (Direct) |
View |